BioSpace News Archive

Drug Development

Cullinan Oncology Announces First Patient Dosed in Phase 1 Trial Evaluating CLN-978, a Novel CD19xCD3 T cell Engager, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Cullinan Oncology, Inc. today announced that the first patient has been dosed in the Phase 1 clinical trial evaluating CLN-978 for the treatment of relapsed/refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL).

August 9, 2023
·
6 min read
BioCapital

Inteleos Names Jasmine Rockett Director of Point of Care Ultrasound Certification Academy

Inteleos, a non-profit global healthcare certification organization, recently appointed Jasmine Rockett as director of the organization’s Point of Care Ultrasound Certification Academy.

August 9, 2023
·
2 min read
Genetown

EyePoint Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual Ophthalmology Virtual Conference

EyePoint Pharmaceuticals, Inc. today announced that Jay S. Duker, M.D., President and Chief Executive of EyePoint Pharmaceuticals will present at the H.C. Wainwright 3rd Annual Ophthalmology Virtual Conference.

August 9, 2023
·
1 min read
Business

Zentalis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updates

Zentalis® Pharmaceuticals, Inc. today announced financial results for the quarter ended June 30, 2023, and highlighted recent corporate accomplishments.

August 9, 2023
·
12 min read
Drug Development

Elicio Therapeutics Announces Publication of Preclinical Data Demonstrating AMP-CpG Adjuvant Can Induce Potent and Durable Immune Response in Epstein-Barr Virus (EBV) Infectious Disease Model

Elicio Therapeutics today announced the publication of preclinical data demonstrating its lymph node-targeting Amphiphile (AMP) adjuvant.

August 9, 2023
·
9 min read
Business

Immunome Reports Second Quarter 2023 Financial Results

Immunome, Inc. today reported financial results for the second quarter ended June 30, 2023 and provided a corporate update.

August 9, 2023
·
14 min read
Biotech Beach

Kintara Therapeutics to Present at the Emerging Growth Conference

Kintara Therapeutics, Inc. today announced that its President and CEO, Robert E. Hoffman will present in the Emerging Growth Conference on Wednesday, August 9, 2023 at 12:00 pm ET.

August 9, 2023
·
3 min read
Deals

T2 Biosystems Regains Compliance with Nasdaq’s Market Value of Listed Securities Requirement

T2 Biosystems, Inc. today announced that it received written notice from the NASDAQ Stock Market LLC (“NASDAQ”) on August 8, 2023 informing the Company that it has regained compliance with the market value of listed securities (“MVLS”) requirement, as set forth in Nasdaq Listing Rule 5550(b)(2).

August 9, 2023
·
4 min read
INSPIRA™ ART100 Completes Usability Study in Boston Massachusetts, U.S.

Inspira™ Technologies OXY B.H.N. Ltd., a company aiming to revolutionize acute respiratory care by empowering breathing without lungs, is proud to announce it has completed a Usability Study in Boston, Massachusetts for its INSPIRA ART100 device.

August 9, 2023
·
3 min read